Press Releases

Home Press Releases
Beta-O2 Names Dr. Yuval Avni CEO.
Sherpa Innoventures joins list of company investors

March, 30, 2015

Beta-O2’s ßAir Bio-artificial Adrenal Device Shows Potential to Treat Adrenocortical Insufficiency and Other Stress-related Disorders

Feb, 19, 2015

First Patient Successfully Implanted in Safety/Efficacy Study of Beta-O2’s ßAir Bio-Artificial Pancreas for Type 1 Diabetes

Oct, 21, 2014

Beta O2 has received a grant from JDRF to conduct a clinical trial of the βAir Bio-Artificial Pancreas as a Potential Cure for Type 1 Diabetes

Sept, 10, 2014